AIG
PPH icon

American International Group’s VanEck Pharmaceutical ETF PPH Stock Holding History

American International Group’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-325
Closed -$19K – 4072
2016
Q1 		$19K Sell
325
-305
-48% -$18K ﹤0.01% 4316
2015
Q4 		$41K Sell
630
-1,391
-69% -$89.8K ﹤0.01% 4002
2015
Q3 		$127K Buy
2,021
+58
+3% +$4.08K ﹤0.01% 3271
2015
Q2 		$139K Buy
+1,963
New +$141K ﹤0.01% 3380

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
AL
Aspiriant LLC Los Angeles, California $3.51B AUM 13.98% 1-Year Est. Return
LFM
Lumina Fund Management New York $164M AUM 27.72% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

American International Group's PPH Position: Q2 2016 in Review

American International Group sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2016, closing a stake of 325 shares — an estimated $19K sold.

American International Group first reported a position in PPH in Q2 2015 and held it in 4 quarters. The position peaked at $139K in Q2 2015. 58 funds tracked by Wall St. Rank hold PPH as of Q2 2016.

  • American International Group reported no remaining VanEck Pharmaceutical ETF position as of Q2 2016 after selling out during the quarter.
  • American International Group sold 325 VanEck Pharmaceutical ETF shares in Q2 2016, an estimated $19K.
  • American International Group first reported a position in VanEck Pharmaceutical ETF in Q2 2015 and held it in 4 quarters.
  • American International Group's VanEck Pharmaceutical ETF position peaked at $139K in Q2 2015.
  • 58 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2016.

Based on American International Group's 13F filing for Q2 2016, filed 11 Aug 2016.